858 related articles for article (PubMed ID: 17550598)
1. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
Ballard HO; Anstead MI; Shook LA
Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
[TBL] [Abstract][Full Text] [Related]
3. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia.
Laughon M; Bose C; Moya F; Aschner J; Donn SM; Morabito C; Cummings JJ; Segal R; Guardia C; Liu G;
Pediatrics; 2009 Jan; 123(1):89-96. PubMed ID: 19117865
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
[TBL] [Abstract][Full Text] [Related]
5. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants.
Oh W; Poindexter BB; Perritt R; Lemons JA; Bauer CR; Ehrenkranz RA; Stoll BJ; Poole K; Wright LL;
J Pediatr; 2005 Dec; 147(6):786-90. PubMed ID: 16356432
[TBL] [Abstract][Full Text] [Related]
6. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
[TBL] [Abstract][Full Text] [Related]
7. Association between early postnatal weight loss and death or BPD in small and appropriate for gestational age extremely low-birth-weight infants.
Wadhawan R; Oh W; Perritt R; Laptook AR; Poole K; Wright LL; Fanaroff AA; Duara S; Stoll BJ; Goldberg R
J Perinatol; 2007 Jun; 27(6):359-64. PubMed ID: 17443198
[TBL] [Abstract][Full Text] [Related]
8. Failure of cromolyn sodium to reduce the incidence of bronchopulmonary dysplasia: a pilot study. The Neonatal Cromolyn Study Group.
Watterberg KL; Murphy S
Pediatrics; 1993 Apr; 91(4):803-6. PubMed ID: 8464671
[TBL] [Abstract][Full Text] [Related]
9. Severe retinopathy of prematurity in extremely low birth weight infants after short-term dexamethasone therapy.
Ramanathan R; Siassi B; deLemos RA
J Perinatol; 1995; 15(3):178-82; quiz 183-4. PubMed ID: 7666264
[TBL] [Abstract][Full Text] [Related]
10. A comparison of two airway suctioning frequencies in mechanically ventilated, very-low-birthweight infants.
Cordero L; Sananes M; Ayers LW
Respir Care; 2001 Aug; 46(8):783-8. PubMed ID: 11463368
[TBL] [Abstract][Full Text] [Related]
11. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
Yoder BA; Harrison M; Clark RH
Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192
[TBL] [Abstract][Full Text] [Related]
12. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial.
Finer NN; Carlo WA; Duara S; Fanaroff AA; Donovan EF; Wright LL; Kandefer S; Poole WK;
Pediatrics; 2004 Sep; 114(3):651-7. PubMed ID: 15342835
[TBL] [Abstract][Full Text] [Related]
13. Use of azithromycin for the prevention of bronchopulmonary dysplasia in preterm infants: a randomized, double-blind, placebo controlled trial.
Ballard HO; Shook LA; Bernard P; Anstead MI; Kuhn R; Whitehead V; Grider D; Crawford TN; Hayes D
Pediatr Pulmonol; 2011 Feb; 46(2):111-8. PubMed ID: 20963840
[TBL] [Abstract][Full Text] [Related]
14. Is the new definition of bronchopulmonary dysplasia more useful?
Sahni R; Ammari A; Suri MS; Milisavljevic V; Ohira-Kist K; Wung JT; Polin RA
J Perinatol; 2005 Jan; 25(1):41-6. PubMed ID: 15538399
[TBL] [Abstract][Full Text] [Related]
15. Nebulized pentoxifylline for prevention of bronchopulmonary dysplasia in very low birth weight infants: a pilot clinical study.
Lauterbach R; Szymura-Oleksiak J; Pawlik D; Warchoł J; Lisowska-Miszczyk I; Rytlewski K
J Matern Fetal Neonatal Med; 2006 Jul; 19(7):433-8. PubMed ID: 16923699
[TBL] [Abstract][Full Text] [Related]
16. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants?
Aly H; Milner JD; Patel K; El-Mohandes AA
Pediatrics; 2004 Sep; 114(3):697-702. PubMed ID: 15342841
[TBL] [Abstract][Full Text] [Related]
17. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation.
Ballard RA; Truog WE; Cnaan A; Martin RJ; Ballard PL; Merrill JD; Walsh MC; Durand DJ; Mayock DE; Eichenwald EC; Null DR; Hudak ML; Puri AR; Golombek SG; Courtney SE; Stewart DL; Welty SE; Phibbs RH; Hibbs AM; Luan X; Wadlinger SR; Asselin JM; Coburn CE;
N Engl J Med; 2006 Jul; 355(4):343-53. PubMed ID: 16870913
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence and risk factors of bronchopulmonary dysplasia among extremely low birth weight newborns of regional birth cohort of south-east Poland].
Kwinta P; Grudzień A; Pawlik D; Olechowski W; Lauterbach R; Pietrzyk JJ
Przegl Lek; 2009; 66(1-2):14-20. PubMed ID: 19485250
[TBL] [Abstract][Full Text] [Related]
19. Outcome of extremely low birth weight infants with leukemoid reaction.
Hsiao R; Omar SA
Pediatrics; 2005 Jul; 116(1):e43-51. PubMed ID: 15930185
[TBL] [Abstract][Full Text] [Related]
20. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
